Evidence map›Paper›PMID 33260345›Full record

ArticleInternational journal of molecular sciences2020

Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma.

Catherine Taylor, Simi Chacko, Michelle Davey, Jacynthe Lacroix, Alexander MacPherson, Nicholas Finn, Gabriel Wajnberg, Anirban Ghosh, Nicolas Crapoulet, Stephen M Lewis and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  9. Recent developments in isolating methods for exosomes.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. [Role and Significance of Bioactive Substances in Sputum
 in the Diagnosis of Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Catherine TaylorAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Simi ChackoAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Michelle DaveyAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Jacynthe LacroixAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Alexander MacPhersonAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Nicholas FinnDr Léon-Richard Oncology Center, Moncton, NB E1C 8X3, Canada.ORCID 0000-0002-4908-6824
Gabriel WajnbergAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.ORCID 0000-0002-4479-4063
Anirban GhoshAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Nicolas CrapouletAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Stephen M LewisAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.ORCID 0000-0001-9537-5822
Rodney J OuelletteAtlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
Atlantic Cancer Research Institute · CAUniversité de Moncton · CA

Funding

Atlantic Canada Opportunities Agency 207369
6 · The paper itself

Abstract

Liquid biopsy is a minimally-invasive diagnostic method that may improve access to molecular profiling for non-small cell lung cancer (NSCLC) patients. Although cell-free DNA (cf-DNA) isolation from plasma is the standard liquid biopsy method for detecting DNA mutations in cancer patients, the sensitivity can be highly variable. Vn96 is a peptide with an affinity for both extracellular vesicles (EVs) and circulating cf-DNA. In this study, we evaluated whether peptide-affinity (PA) precipitation of EVs and cf-DNA from NSCLC patient plasma improves the sensitivity of single nucleotide variants (SNVs) detection and compared observed SNVs with those reported in the matched tissue biopsy. NSCLC patient plasma was subjected to either PA precipitation or cell-free methods and total nucleic acid (TNA) was extracted; SNVs were then detected by next-generation sequencing (NGS). PA led to increased recovery of DNA as well as an improvement in NGS sequencing parameters when compared to cf-TNA. Reduced concordance with tissue was observed in PA-TNA (62%) compared to cf-TNA (81%), mainly due to identification of SNVs in PA-TNA that were not observed in tissue.

Indexed as

High-Throughput Nucleotide SequencingAdultAgedAged, 80 and overAllelesBiomarkers, TumorCarcinoma, Non-Small-Cell LungCell-Free Nucleic AcidsErbB ReceptorsExtracellular VesiclesFemaleHumansLiquid BiopsyLung NeoplasmsMaleMiddle AgedBiomarkers, TumorCell-Free Nucleic AcidsErbB ReceptorsPeptidesbiomarkersexosomesextracellular vesiclesgenetic profilingliquid biopsylung cancernext generation sequencing

Identifiers

PMID33260345
PMCPMC7730179
OpenAlexW3108227279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.